Thermo Fisher ups clinical, commercial capabilities with $50m investment
Thermo Fisher Scientific is investing $50m to further expand its biologic drug substance capabilities for both clinical and commercial supply.
Archives for April 25, 2019
Biogen drops Alzheimer’s drug but ‘focus remains’ on neuroscience
Biogen will halt all clinical trial activity on its Alzheimer’s drug, aducanumab, after its failure in Phase III trials, according to its first quarter financials.
Poseida raises $142m in Series C financing to advance CAR-T products
Poseida Therapeutics raises $142m in Series C financing round led by current marketer of CAR-T therapy Kymriah, Novartis.
Start Codon realizes biopharma companies ‘full potential’
UK-based investors launch Start Codon to recruit up to 50 start-up biotech companies for investment and risk mitigation opportunities over the next five years.